Drkoop Seeks Hearing to Block Nasdaq Removal

Share this article:
Healthcare information provider Drkoop.com yesterday requested a hearing before the Nasdaq exchange's qualifications board to contest the impending removal of its stock listing.


The hearing is scheduled for March 30. The removal of Drkoop's stock listing will be delayed until the hearing. There is no assurance Nasdaq will grant the Santa Monica, CA-based company's request for a continued listing.


In December, the Nasdaq notified Drkoop that its stock had failed to meet the $1 minimum bid requirement for 30 consecutive days and would be removed. Drkoop's stock closed at 25 cents on Wednesday.


Drkoop considered a reverse stock split to increase its stock price and prevent removal of its listing. However, the company decided against the move after several major stockholders voiced opposition.


Instead, Drkoop pursued a cost-cutting policy in an effort to reduce monthly expenses to less than $1 million, down from a high of $8 million in March 2000. It has closed its Austin, TX, office and reduced its staff to 35, down from a high of 185 when the company was founded by former U.S. Surgeon General C. Everett Koop.


Share this article:
You must be a registered member of Direct Marketing News to post a comment.

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in News

DMA 2014 Kicks Off Under New Management

DMA 2014 Kicks Off Under New Management

Thomas Benton and Jane Berzan will preside over an event indicative of an association serving a wider array of industry segments.

De Quinto Tapped as Coke's Next CMO

De Quinto Tapped as Coke's Next CMO

The president of the company's Iberia Business Unit will take over from Joe Tripodi upon his retirement in February.

Customer Centricity Is Spurring Marketing-Tech Investments

Customer Centricity Is Spurring Marketing-Tech Investments

A majority of marketers rank customer satisfaction improvements as paramount in the technology investment decisions.